Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ARKIDENTA ApS
APS
Active
CVR 27930425
Storgade 31, 4180
Sorø
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2004 · 21 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
ARKIDENTA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-6
-6
-6
-6
-7
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-6
-6
-6
-6
-7
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-6
-6
-6
-6
-7
Net financials
-16
-16
-16
-16
-16
Profit before tax
-22
-22
-22
-22
-23
Tax
-23
-22
-25
-33
-4
Net profit
1
0
3
10
-19
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
23
22
25
33
4
Equity
-404
-404
-401
-391
-410
Long-term debt
0
0
0
0
0
Short-term debt
427
426
426
424
414
Total debt
427
426
426
424
414
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-675000.0%
This company
2021
2025
Equity ratio
-9887.1%
This company
38.2%
Market median
-25982% vs market
2021
2025
Return on equity
-1856000.0%
This company
18.4%
Market median
-10087057% vs market
2021
2025
Net profit margin (of gross profit)
-1856000.0%
This company
2021
2025
Asset turnover (of gross profit)
-1.63×
This company
2021
2025
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on ARKIDENTA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network